Navigation Links
Genetic therapy reverses nervous system damage in animal model of inherited human disease

for an enzyme called lysosomal alpha-mannosidase or LAMAN.

"Shortly after birth, brain tissue is still physically maturing, which means that there is a particularly important window of opportunity for gene therapy in infants," Wolfe said. "In our study, we could see that gene therapy used during this particular time led to a restoration of damaged neurons, even though the lesions that represent the disease were already extensive."

According to Charles H. Vite, the lead author of the paper and an assistant professor of veterinary neurology at Penn, the treated cats not only demonstrated dramatic clinical improvement, but MRI also revealed that white matter tracks, myelin, in the brain had been largely restored.

"As we move toward the clinical use of this therapy in humans, we must develop and utilize non-invasive methods to monitor the regression of the disease following treatment," Vite said. "The ability to monitor the improvement in brain myelination in alpha-mannosidosis using imaging allows the clinician to see improvement in brain pathology without the need for brain biopsy."

"Lysosomal storage diseases are particularly good candidates for gene therapy because, as we show with LAMAN, active enzymes from genetically corrected cells will be secreted into brain tissue and taken up by neighboring cells, Wolfe said. "In this case we see that storage lesions throughout the brain had been greatly reduced, even though gene transfer was limited to areas surrounding where injections had been made."

The large animal study also demonstrated that only a limited number of injections are necessary to introduce the working LAMAN gene, one of the first steps that will prepare this particular gene therapy for practical use in humans. The gene is transported via a neutralized virus that "infects" cells with the functioning gene. Since the blood-brain barrier would block the virus carrying the gene if it were circulating in the bloodstream,
'"/>

Source:University of Pennsylvania


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Ants Genetic Engineering Leads To Species Interdependency
4. Genetic Variation Visualization - From EMBL
5. Genetically modified rice in China benefits farmers health, study finds
6. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
7. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
8. Genetic defects give the immune system the green light to attack the pancreas
9. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
10. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
11. Researchers Find New Technique To Identify Fetal Genetic Material From Amniotic Fluid

Post Your Comments:
(Date:11/4/2009)..., REDWOOD CITY, Calif., Oct. 20 D...ity and authentication solutions, today announced ...-of-sale (POS) software for quick-service restaura... their NextGen POS and Classic POS solutions. WAND... biometrics to boost cashier accountability and de...
(Date:11/4/2009)..., RIDGE, N.Y., Oct. 21 What,s the...reventing accidental death resulting from prescrip...ts with good intentions, however, may be unaware t...cting their teens from the ticking timebomb of pre... leader in premium-quality medical supplies, has f...
(Date:11/4/2009)..., WALL, N.J., Oct. 26 B...YI), a leader in finger-based biometric identifica...tity solutions at the AABB TXPO conference being h...ber 25-27 2009. BIO-key will provide hands-on prod...ication technology in booth #424. Also, at 5 PM on...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 220 20 Tackles Taboo Health Issue Affecting Millions of Women 54099 120 20 Tackles Taboo Health Issue Affecting Millions of Women 54099 2Bay Area IVF Group Offers New In House Embryo Donation Program 54096 1Bay Area IVF Group Offers New In House Embryo Donation Program 54096 2Could Your Family Be The Family of the Year 3F 54093 1Could Your Family Be The Family of the Year 3F 54093 2Could Your Family Be The Family of the Year 3F 54093 3Could Your Family Be The Family of the Year 3F 54093 4Could Your Family Be The Family of the Year 3F 54093 5
...cular technology developed by a University of Colo...rms in undersea hydrothermal vents has been used t... fluid of Denver children suffering from cystic fi...herapies. , Instead of standard culturing techniq... to rapidly detect, identify and classify pathogen...
...ALLIS, Ore. The spread of two invasive alien fres...agga mussel appears to be controlled in part by c...assessment based on water chemistry suggests the G...n line for invasion. , Results of the study were ...iers in Ecology and the Environment, a journal of ...
...INGTON, Dec. 3 A team of researchers from the Wel...eral Hospital (MGH) and Harvard Medical School (HM...em to peer through the eyes of a mouse and monitor... the Dec. 1 issue of the journal Optics Letters, p...am describes how they used the device, called a re...
Other Biology News:CU-Boulder technology used to identify unexpected bacteria in cystic fibrosis patients 2New map outlines risk of zebra mussel invasion 2New map outlines risk of zebra mussel invasion 3New map outlines risk of zebra mussel invasion 4Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream 2Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream 3
(Date:11/5/2009)...ry and vision correction experts listed in the Tru...ed at the recently concluded American Academy of O...cisco, California. Dr. Stephen Brint, MD, Dr. Fred...Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr....Edward Manche, MD, and Dr. Parag Majmudar, MD, all...
(Date:11/4/2009)...nthrax Vaccine Program must be stopped. Scott Mil...ot;A Call to Arms:2009 Edition" and the one-h...he Human Anthrax Vaccine Story" to inform the...secret government science turned into for-profit h...s victims. It is available for world-wide licensi...
(Date:11/4/2009)...4 Zyngenia, Inc., a privately held...n antibody drug development, today announced that ...m New Enterprise Associates (NEA), one of the worl...l be used to create novel, multi-specific antibody...l targets with a single agent. The company will in...
(Date:11/4/2009)... 4 Emerson Resources, Inc ., a ...nounced that it has formed a strategic partnership...zation that specializes in the agrichemical and re...evelopment capabilities. The exclusive partnership...t Westbrook, CEO of Bio Research, who is spearhead...
Breaking Biology Technology:Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Emerson Resources Forges Strategic Partnership with Bio Research 2
...ril 15 ChemAxon, a software,solutions provider fo...rsion,5.2 of their cheminformatics toolkits, Marvi...lities added, new integration options and improvem...em is a software suite of application programming ...I,s) used by life science informatics,architects a...
...Stemedica Cell Technologies, Inc., a leader in adu... that Lee Ann Laurent-Applegate PD & MER has j...his capacity, she will help Stemedica advance the ...io-processing and cellular delivery system for bur... San Diego, CA (PRWEB) April 15, 2009 -- Stemedica...
... at the American Society of Clinical Oncology (ASC...Conference Call Today at 5:00 p.m. Eastern Time - ...th, Inc. (Nasdaq: GHDX ) today announced that t...t to predict the likelihood of recurrence for stag...that the colon cancer Recurrence Score(R) provided...
Other Biology Technology:ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks 2Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 2Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 3Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher 4Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 2Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 3Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 4
X-Gal from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Mouse / Rat WNK1 Polyclonal Antibody, Unconjugated from R&D Systems
...f excess dye terminators, template DNA, primers, s...quencing products have proved critical for both st...gned to work with dye terminator cycle sequencing ...e unique uniformity of the magnetic paeticles guar...
LEVAMISOLE SOLUTION from Invitrogen
Biology Products: